TWiV 856: COVID-19 clinical update #98 with Dr. Daniel Griffin

<p>In COVID-19 clinical update #98, Daniel Griffin reviews COVID-19 in South Africa, recognition of Omicron by ancestral T cells, booster effectiveness against disease, infection and vaccination in pregnant women, early Remdesivir to prevent progression to severe disease, management of hospitalized adults, Tocilizumab in hospitalized patients, vaccination and long COVID, and the true toll of the pandemic.</p> <p>Click arrow to play<br /> Download <a href= "http://traffic.libsyn.com/twiv/TWiV853.mp3">TWiV 853</a> (58 MB .mp3, 48 min)<br /> Subscribe (free): <a href= "http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=300973784">iTunes</a>, <a href="https://www.google.com/podcasts?feed=aHR0cDovL3R3aXYubWljcm9iZXdvcmxkLmxpYnN5bnByby5jb20vdHdpdg%3D%3D">Google Podcasts</a>, <a href= "http://twiv.microbeworld.libsynpro.com/twiv">RSS</a>, <a href="http://eepurl.com/Gcw59">email</a></p> <p>Become a <a href= "https://www.microbe.tv/contribute">patron</a> of TWiV!</p> <h3><strong>Links for this episode</strong></h3> <ul> <li>COVID-19 in South Africa (<a href= "https://www.nicd.ac.za/wp-content/uploads/2022/01/COVID-19-Special-Public-Health-Surveillance-Bulletin-January-2022.pdf">pdf</a>)</li> <li>Ancestral T cells <a href= "https://www.nature.com/articles/s41591-022-01700-x">recognize Omicron</a> (Nat Med)</li> <li><a href= "https://www.nature.com/articles/s41591-022-01699-1">Booster effectiveness</a> against COVID-19, England (Nat Med)</li> <li>Cases and hospitalization by <a href= "https://www.cdc.gov/mmwr/volumes/71/wr/mm7104e1.htm?s_cid=mm7104e1_e&ACSTrackingID=USCDC_921-DM73434&ACSTrackingLabel=MMWR%20Early%20Release%20-%20Vol.%2071%2C%20January%2019%2C%202022&deliveryName=USCDC_921-DM73434"> vaccination status</a> (MMWR)</li> <li>Infection and vaccination in <a href= "https://www.nature.com/articles/s41591-021-01666-2">pregnant women</a>, Scotland (Nat Med)</li> <li><a href= "https://www.nejm.org/doi/full/10.1056/NEJMoa2116846">Early Remdesivir</a> to prevent progression to severe disease (NEJM)</li> <l